133 related articles for article (PubMed ID: 38463640)
1. The TGF-β/MMP9/RAGE axis induces sRAGE secretion by neutrophils and promotes oral carcinogenesis.
Chen X; Wang N; Jing C; Li J; Liu X; Yang Y; Song T; Jia H
Biochem Biophys Rep; 2024 Jul; 38():101676. PubMed ID: 38463640
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1 and IL-17A comediate the protumor phenotype of neutrophils to regulate the epithelial-mesenchymal transition in oral squamous cell carcinoma.
Yu T; Tang Q; Chen X; Fan W; Zhou Z; Huang W; Liang F
J Oral Pathol Med; 2021 Apr; 50(4):353-361. PubMed ID: 33164231
[TBL] [Abstract][Full Text] [Related]
3. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Ren L; Lou Y; Sun M
Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479
[TBL] [Abstract][Full Text] [Related]
4. Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion.
Maldonado LAG; Nascimento CR; Rodrigues Fernandes NA; Silva ALP; D'Silva NJ; Rossa C
Int J Biochem Cell Biol; 2022 Dec; 153():106330. PubMed ID: 36343916
[TBL] [Abstract][Full Text] [Related]
5. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
[TBL] [Abstract][Full Text] [Related]
6. The downregulation of IGFBP3 by TGF-β signaling in oral cancer contributes to the osteoclast differentiation.
Park J; Jung MJ; Chung WY
Biochem Biophys Res Commun; 2021 Jan; 534():381-386. PubMed ID: 33256984
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
Son SH; Park J; Jung MJ; Lee SK; Kim H; Kim KR; Park KK; Chung WY
Eur J Oral Sci; 2021 Feb; 129(1):e12750. PubMed ID: 33503283
[TBL] [Abstract][Full Text] [Related]
8. The promoting effect of neutrophil-derived BAFF molecule on the proliferation and life span of CAL-27 oral squamous carcinoma cells.
Jablonska E; Iwaniuk A; Ratajczak-Wrona W; Grubczak K; Dziemianczyk-Pakiela D; Moniuszko M; Nowak K; Borys J; Garley M
Immunobiology; 2022 Sep; 227(5):152247. PubMed ID: 35933760
[TBL] [Abstract][Full Text] [Related]
9. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.
Zhang H; Mao YF; Zhao Y; Xu DF; Wang Y; Xu CF; Dong WW; Zhu XY; Ding N; Jiang L; Liu YJ
Oxid Med Cell Longev; 2021; 2021():8889313. PubMed ID: 33628393
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Secernin 1 inhibit cell invasion and migration by activating the TGF-β/Smad3 pathway in oral squamous cell carcinomas.
Xiao L; Zhang T; Zheng K; Xiao Q; Zhang W; Zhang D; Wu D; He C; Zhou Y; Liu Y
Sci Rep; 2023 Sep; 13(1):14922. PubMed ID: 37691034
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
13. Soluble Receptor for Advanced Glycation End Product Is Involved in the Inflammatory Response of Human Adenovirus-Infected Patients.
Xu W; Wu CJ; Jiao YM; Mei XL; Huang L; Qin EQ; Tu B; Zhao P; Wang LF; Chen WW
Front Microbiol; 2022; 13():923215. PubMed ID: 35875560
[TBL] [Abstract][Full Text] [Related]
14. RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension.
Jia D; He Y; Zhu Q; Liu H; Zuo C; Chen G; Yu Y; Lu A
Cardiovasc Res; 2017 May; 113(6):586-597. PubMed ID: 28407046
[TBL] [Abstract][Full Text] [Related]
15. Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis.
Scavello F; Zeni F; Milano G; Macrì F; Castiglione S; Zuccolo E; Scopece A; Pezone G; Tedesco CC; Nigro P; Degani G; Gambini E; Veglia F; Popolo L; Pompilio G; Colombo GI; Bianchi ME; Raucci A
Int J Biol Sci; 2021; 17(10):2399-2416. PubMed ID: 34326683
[TBL] [Abstract][Full Text] [Related]
16. A novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive phenotype of oral squamous cell carcinoma via enhanced EGFR signaling.
Son HK; Kim D; Lim Y; Kim J; Park I
BMC Cancer; 2020 Nov; 20(1):1163. PubMed ID: 33246423
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury.
Miyagawa T; Iwata Y; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Kamikawa Y; Miyake T; Kitajima S; Toyama T; Hara A; Sakai N; Shimizu M; Furuichi K; Munesue S; Yamamoto Y; Kaneko S; Wada T
Biol Open; 2022 Jan; 11(1):. PubMed ID: 34812852
[TBL] [Abstract][Full Text] [Related]
19. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma.
Wang N; Wang Q; Chi J; Xiang F; Lin M; Wang W; Wei F; Feng Y
Cancer Sci; 2019 Feb; 110(2):519-529. PubMed ID: 30565803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
